PCIB007 Dry material_edited_edited.jpg

Synthetic biologics
for a safer world

Versatile physical properties & potent antimicrobial activity
Better for you and better for the environment 

Presentations

MargolisScreenshot.v2.jpg

Dr. Bevilacqua presents at 
FDA-sponsored, Duke-Robert J. Margolis MD, Center for Health Policy Conference on "Understanding the Development Challenges Associated with Emerging Non-traditional Antibiotics"


(1) This work has been supported by US Army Medical Research & Materiel Command through the Military Burn Research Program under Award No. W81XWH-15-2-0065 and by the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program under Award No. W81XWH-16-1-0561. Opinions, interpretations, conclusions and recommendations are those of Amicrobe and are not necessarily endorsed by the Department of Defense. Ongoing support comes from CARB-X and is provided by the Department of Health & Human Services Asst. Secretary for Preparedness & Response (BARDA) and Wellcome Trust through Boston University subaward 4500002454 and the Department of Health and Social Care (U.K.) through subaward 4500003403.